Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
People with repeat monkeypox infections and those who were vaccinated are less likely to develop severe symptoms.
Understanding how this variant helped people fend off the virus could lead to better ways to protect against COVID.
People with greater immune resilience may be at lower risk for severe COVID-19, AIDS and recurrent skin cancer, NIAID grantees find.
NIH-funded study suggests need to boost CD8+ T cell response after infection.
The number of pediatric inpatient units in hospitals fell 19% from 2008 to 2018.
Studies suggest that the Jynneos vaccine offers substantial protection, but more real-world research is needed.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.
Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.
Younger adults and stem cell transplant recipients are at highest risk for measles and mumps.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
Many experts argue that COVID-19 cannot be curbed without vaccinating children. But others aren’t so sure.
Scientific evidence appears to show that vaccine-induced immunity is stronger than what the body generates after natural infection.
While the United States is getting closer to this point, most health experts caution, it still has ground to cover.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
The coronavirus vaccines are safe and should be effective even for people with advanced cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.